Effects of docosahexaenoic acid–rich n−3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study-Reference-Cited by-同舟云学术

Effects of docosahexaenoic acid–rich n−3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study

Published:2008-06-01 Issue:6 Volume:87 Page:1616-1622
ISSN:0002-9165
Container-title:The American Journal of Clinical Nutrition
language:en
Short-container-title:

Author:

Vedin Inger¹,Cederholm Tommy¹,Freund Levi Yvonne¹,Basun Hans¹,Garlind Anita¹,Faxén Irving Gerd¹,Jönhagen Maria Eriksdotter¹,Vessby Bengt¹,Wahlund Lars-Olof¹,Palmblad Jan¹

Affiliation:

1. From the Department of Medicine (IV, JP) and the Department of Neurobiology, Caring Sciences and Society (YFL, AG, GFI, MEJ, and L-OW), Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden, and the Department of Public Health and Caring Sciences (TC, HB, and BV) Division of Geriatrics (HB) and the Division of Clinical Nutrition and Metabolism Research (TC and BV), Upp

Publisher

Oxford University Press (OUP)

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

http://academic.oup.com/ajcn/article-pdf/87/6/1616/23919282/znu00608001616.pdf

Reference37 articles.

1. Omega-3 fatty acids in inflammation and autoimmune diseases;Simopoulos;J Am Coll Nutr,2002

2. Dietary n−3 fats as adjunctive therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritis;James;Prostaglandins Leukot Essent Fatty Acids,2003

3. Omega-3 fatty acids and inflammation;Mori;Curr Atheroscler Rep,2004

4. Secondary prevention of coronary artery disease with omega-3 fatty acids;Jacobson;Am J Cardiol,2006

5. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study;Schaefer;Arch Neurol,2006

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of omega‐3, DHA, EPA, Souvenaid® in Alzheimer's disease: A systematic review and meta‐analysis;Neuropsychopharmacology Reports;2024-06-25

2. Effects of DHA on cognitive dysfunction in aging and Alzheimer's disease: The mediating roles of ApoE;Progress in Lipid Research;2024-01

3. Advancing age, nutraceuticals, and neuroprotection;A Review on Diverse Neurological Disorders;2024

4. The Effect of Fat Intake with Increased Omega-6-to-Omega-3 Polyunsaturated Fatty Acid Ratio in Animal Models of Early and Late Alzheimer’s Disease-like Pathogenesis;International Journal of Molecular Sciences;2023-11-30

5. Gut microbiome-targeted therapies for Alzheimer’s disease;Gut Microbes;2023-11-07